Kevin M. Brennan's Insider Trades & SAST Disclosures

Kevin M. Brennan's most recent trade in Xilio Therapeutics Inc was a trade of 60,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 1, 2025.

Share

Note

This is a custom search result for pattern Kevin M. Brennan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Show

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Xilio Therapeutics Inc	Kevin M. Brennan	SVP, FINANCE AND ACCOUNTING	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	60,000	60,000	-		-	Stock Option (right to buy)
Xilio Therapeutics Inc	Kevin M. Brennan	SVP, FINANCE AND ACCOUNTING	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jan 2025	5,000	5,000	-		-	Common Stock
Xilio Therapeutics Inc	Kevin M. Brennan	SVP, FINANCE AND ACCOUNTING	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jan 2025	5,000	15,000	-		-	Restricted Stock Units
Xilio Therapeutics Inc	Kevin M. Brennan	SVP, FINANCE AND ACCOUNTING	Sale of securities on an exchange or to another person at price $ 0.98 per share.	01 Jan 2025	1,803	3,197	-	1.0	1,774	Common stock
Xilio Therapeutics Inc	Kevin M. Brennan	SVP, FINANCE AND ACCOUNTING	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2024	26,000	26,000	-		-	Stock Option (right to buy)
Xilio Therapeutics Inc	Kevin M. Brennan	SVP, FINANCE AND ACCOUNTING	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2024	20,000	20,000	-		-	Stock Option (right to buy)
Xilio Therapeutics Inc	Kevin Brennan M.	SVP, FINANCE AND ACCOUNTING	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2024	20,000	20,000	-		-	Restricted Stock Units
Xilio Therapeutics Inc	Kevin M. Brennan	SVP, FINANCE AND ACCOUNTING	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Apr 2023	55,000	55,000	-		-	Stock Option (right to buy)

Showing 1 to 8 of 8 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades